Clinical decision support
Also, TruScreen has secured a new distribution deal to reenter India.
It joins Lunit and Us2.ai in the vendor-neutral, cloud-based marketplace of medical AI solutions.
Aktiia announced an oversubscribed $42 million Series B round, and Basil Systems secured $11.5 million in funding.
Claimed to be a world's first, the LLM-driven model has demonstrated over 90% accuracy.
The community-based program targets to screen 260,000 women.
Also, an AI-powered breath test for diagnosing silicosis has been developed in Sydney.
Also, Cureskin from India has launched an AI-powered hair analysis feature on its mobile application.
The hospital-focused telehealth and virtual care delivery company, which currently works with more than 70 health systems, will use the funds to scale its reach.
The study has demonstrated the potential of predictable movement stimuli as a behavioural marker of autism spectrum disorder.
Developed using a corpus of 38 million clinical texts, the open-source model scored 86% in the Korean Medical Licensing Examination.